3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Uterine Cervical Neoplasms
6
Uterine Cervical Dysplasia
4
Papillomavirus Infections
1
Pancreatic Neoplasms
1
Colorectal Neoplasms
1
Acquired Immunodeficiency Syndrome
1
Interventions
Human Papillomavirus Recombinant Vaccine nonavalent
9
Papillomavirus Vaccines
8
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
8
Surveys and Questionnaires
6
Educational Status
6
Blood Specimen Collection
5
Vaginal Smears
4
Radiotherapy, Intensity-Modulated
4
Methods
4
Human Papillomavirus DNA Tests
4
Early Intervention, Educational
4
Cisplatin
4
Carboplatin
4
Patient Navigation
3
Mass Screening
3
Taxes
2
Standard of Care
2
Radiation
2
Practice Guidelines as Topic
2
Papanicolaou Test
2
Paclitaxel
2
Motivational Interviewing
2
Interviews as Topic
2
Electrocoagulation
2
Docetaxel
2
Cytological Techniques
2
Cryotherapy
2
Colposcopy
2
utomilumab
1
toripalimab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Papillomavirus Infections
×
Acetic Acid
×
Clear all
NCT07240220
2026-01-15
Merck-4
Indiana University
Phase NA
Not yet recruiting
2,500 enrolled